openPR Logo
Press release

XClinical embarks on cooperation with Stryker Osteosynthesis

03-02-2010 11:08 AM CET | Health & Medicine

Press release from: XClinical GmbH

XClinical embarks on cooperation with Stryker Osteosynthesis

XClinical GmbH embarks on cooperation with Stryker Osteosynthesis, a subsidiary of the Stryker Corporation

XCLINICAL GMBH, Munich, Germany – 25 FEB 2010 – XClinical, a European vendor of software products for eClinical trials known for its innovative and user-friendly CDISC ODM-certified EDC software suite MARVIN, announced today that Stryker Osteosynthesis, a subsidiary of the Stryker corporation, has decided to use XClinical’s EDC Software MARVIN.

Stryker is set to soon start using the software solution in an International Multicentre Post-Market Follow-Up Evaluation. Five hundred patients will be enrolled in the study, which will be conducted throughout several European countries including Spain, Norway and Belgium. The overall duration including preparation and closeout periods is estimated to run for five years from the “first patient/first visit” to “last patient/last visit”. A second project to be conducted with MARVIN is already being planned. “It’s the first time we’re using EDC at Stryker Osteosynthesis,” said Nils Reimers, Manager Clinical Research at Stryker Global Medical Sciences. “We decided on XClinical’s MARVIN for several reasons. We were impressed by the system’s user friendliness and the intuitive use. The prompt query management which simplifies and smoothes the investigator’s workflow also convinced us of XClinical’s system.”

Initial contact between XClinical and Stryker Osteosynthesis was made in November 2008. XClinical not only provided the system, but also supported Stryker in the introduction of EDC to its internal processes. “We see ourselves not only as a software vendor, but also as a service provider,” said Dr Claus Lindenau, Head of Business Development at XClinical. “The introduction of an EDC system implicates lots of changes in internal processes. Up to now we have gathered over eight years of experience with Electronic Data Capture and related issues, and are happy to pass this knowledge on to others.”

With Stryker Osteosynthesis, XClinical adds another global manufacturer of medical devices to its portfolio of MedTech clients. Comprehensive knowledge and experience in this area strengthen XClinical’s position as a professional partner not only for pharmaceutical companies, but for MedTech companies as well.

About XClinical
XClinical GmbH (www.xclinical.com), an innovative EDC-CDM system vendor based in Munich, Paris and Boston, USA, provides solutions for the electronic conduct of all types of clinical trials, post-marketing studies and registries.
XClinical develops and markets MARVIN, a CDISC ODM-certified online platform for Electronic Data Capture (EDC), Clinical Data Management (CDM) and Clinical Trial Management (CTM).

About Stryker Osteosynthesis
Stryker Osteosynthesis (www.osteosynthesis.stryker.com), founded 1904 in Kiel/Germany, is a subsidiary of the Stryker Corporation based in Michigan/USA. It’s the only subsidiary of the Stryker Corporation focusing on the intramedullar treatment of long bone fracture. At its location in Kiel, Stryker develops and produces medical nail implants, bone screws and instruments mainly for the treatment of fractures. Today, Stryker Osteosynthesis has become the world’s market leader in this sector: every 2.1 minutes, a product from Kiel is implanted in a patient.

XClinical GmbH
Katharina Lang
Siegfriedstraße 8
80803 Munich / Germany
+49/(0)89 45 22 77 5220
press@xclinical.com
www.xclinical.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release XClinical embarks on cooperation with Stryker Osteosynthesis here

News-ID: 121989 • Views: 1342

More Releases from XClinical GmbH

XClinical integrates INCA, Medical Coding software, with its EDC system MARVIN
XClinical releases version 1.6. of its coding system INCA XClinical GmbH, Munich, Germany, May 8, 2014 – XClinical, a global provider of eClinical solutions, today announces the availability of INCA version 1.6, medical coding software featuring MedDRA and WHODrug dictionaries, including an automated web interface to EDC systems such as MARVIN. INCA (“Integrated Coding Architecture”) is a web-based application that enables users to classify health related data such as patient medications and
XClinical CRO Executive Forum
XClinical hosts its first CRO Executive Forum on May 10, 2011 in Aying, Germany. XClinical GmbH, Munich, Germany – April 14, 2011 – XClinical, a European vendor of innovative software products for eClinical trials known for its innovative and user-friendly CDISC ODM-certified EDC software suite MARVIN, hosts its first CRO Executive Forum especially designed for CEOs of CROs on May 10, 2011 in Aying, Germany. The concept In 2010, XClinical started to provide
XClinical’s “MARVIN4KIDS” at the DIA Geneva
XClinical presents the initiative “MARVIN4KIDS” at the DIA Annual EuroMeeting in Geneva XClinical GmbH, Munich, Germany – March 25, 2011 – XClinical, a European vendor of innovative software products for eClinical trials known for its innovative and user-friendly CDISC ODM-certified EDC software suite MARVIN, presents the initiative “MARVIN4KIDS” for the first time at the DIA Annual EuroMeeting in Geneva. The conference takes place from March 28 to 30. “MARVIN4KIDS” MARVIN4KIDS is an XClinical
XClinical and IDDI: The best of 2 worlds
The IWR/IVR system ID-netTM developed by IDDI now provides an interface to MARVIN, XClinical’s EDC system XClinical GmbH, Munich, Germany – March 25, 2011 – XClinical, a European vendor of innovative software products for eClinical trials known for its innovative and user-friendly CDISC ODM-certified EDC software suite MARVIN, presents the web-based open interface of IDDI’s ID-netTM to XClinical’s EDC system MARVIN at the DIA Annual EuroMeeting in Geneva. About ID-netTM ID-netTM

All 5 Releases


More Releases for Clinical

Clinical solutions
Are you spending more time with yellow files than with patients? Healthbridge can change that with our intuitive and easy to use clinical platform that is designed specifically for the medical practitioner at the practice. smaller2 Easily access patient information Cloud-based technology enables you to store rich clinical information that can be easily accessed as and when you need it. Medical billing software innovation Become a paperless practice Create scripts, sick notes, and clinical notes electronically. Plus, have
Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation. This is the premier interdisciplinary forum for
Clinical Trial Management System
According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019. Request Report TOC @ https://www.persistencemarketresearch.com/methodology/3017
Clinical Nutrition Conference 2018
Clinical nutrition is essential for patients in healthcare to deal with sickness, injuries, surgery and for proper recovery. It helps in preventing malnutrition, restoring body tissue and boosting energy and immunity in the body. It can be provided with a proper diet plan and feeding the patient with essential foods that revive the patient’s body the patient can also be given healthy supplements for proteins, vitamins etc. The preferred route
Clinical Communication
According to a recent market report published by Persistence Market Research titled “Clinical Communication and Collaboration Market: Global Industry Analysis (2012–2016) and Forecast (2017–2025),” revenue from the global clinical communication and collaboration market was US$ 138.5 Mn in 2012 and US$ 214.8 Mn in 2016, representing a CAGR of 11.6% from 2012 to 2016. This revenue growth is attributed to addition of new features in clinical communication and collaboration solutions.
Europe Clinical Nutrition Market
According to the report “Europe Clinical Nutrition Market,” published by Market Data Forecast, the global market is projected to reach USD 12.45 billion by 2021 from USD 9.65 billion in 2016, at a CAGR of 5.29% from 2016 to 2021. Clinical nutrition is the practice of analysing if a person is consuming an adequate amount of nutrients for good health. A clinical nutritionist is concerned with how nutrients in food are